Les nodo-paranodopathies, un concept en plein essor

Mahdi-Rogers, 2014, Economic costs and quality of life in chronic inflammatory neuropathies in southeast England, Eur J Neurol, 21, 34, 10.1111/ene.12245 Mahdi-Rogers, 2014, Epidemiology of chronic inflammatory neuropathies in southeast England, Eur J Neurol, 21, 28, 10.1111/ene.12190 Svahn, 2014, Pathophysiology and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathies, Rev Neurol (Paris), 170, 808, 10.1016/j.neurol.2014.10.009 Mathey, 2015, Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype, J Neurol Neurosurg Psychiatry, 86, 973, 10.1136/jnnp-2014-309697 Van den Bergh, 2010, European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripher, Eur J Neurol, 17, 356, 10.1111/j.1468-1331.2009.02930.x Uncini, 2015, Nodopathies of the peripheral nerve: an emerging concept, J Neurol Neurosurg Psychiatry, 86, 1186, 10.1136/jnnp-2014-310097 Faivre-Sarrailh, 2013, Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases, Front Cell Neurosci, 7, 196, 10.3389/fncel.2013.00196 Doppler, 2015, Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies, J Neurol Neurosurg Psychiatry, 86, 720, 10.1136/jnnp-2014-309916 Manso, 2016, Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects, Brain, 139, 1700, 10.1093/brain/aww062 Vallat, 2017, Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies, Neuromuscul Disord, 27, 290, 10.1016/j.nmd.2016.10.008 Uncini, 2013, Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies, Clin Neurophysiol, 124, 1928, 10.1016/j.clinph.2013.03.025 Wakerley, 2014, Guillain-Barré and Miller Fisher syndromes – new diagnostic classification, Nat Publ Gr, 10 Ng Man, 2012, Neurofascin as a target for autoantibodies in peripheral neuropathies, Neurology, 79, 2241, 10.1212/WNL.0b013e31827689ad Querol, 2014, Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg, Neurology, 82, 879, 10.1212/WNL.0000000000000205 Devaux, 2016, Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy, Neurology, 86, 1, 10.1212/WNL.0000000000002418 Querol, 2013, Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy, Ann Neurol, 73, 370, 10.1002/ana.23794 Miura, 2015, Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia, Brain, 138, 1484, 10.1093/brain/awv054 Doppler, 2016, Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy, Brain, 1 Delmont, 2017, Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy, Brain, 10.1093/brain/awx124 Zhang, 2017, Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury, Exp Neurol, 49 Sudo, 2014, Glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition, PLoS One, 9 Wong, 2016, Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy, J Neurol Neurosurg Psychiatry, 87, 275, 10.1136/jnnp-2014-309964